A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.
An international team of scientists has developed a new set of global clinical guidelines for obesity aimed at better diagnosing and categorizing the condition, according to a report published in The Lancet Diabetes and Endocrinology.
A new Northwestern Medicine study has discovered that achieving equity in various social drivers of health — but particularly education — has the potential to nearly eliminate disparities in maternal heart health.
Investigators led by Pinelopi Kapitsinou, MD, have discovered that inhibiting the hypoxia-driven MCT4 protein in kidney endothelial cells may halt the progression of ischemic acute kidney injury to chronic kidney disease, according to a recent study published in the Journal of Clinical Investigation.
Transcatheter heart valve replacement significantly improved outcomes in patients with severe valvular heart diseases compared to standard care alone, according to two recent clinical trials published in the New England Journal of Medicine.
Patients with a subtype of glioblastoma who received a combination treatment of a PARP inhibitor and standard chemotherapy did not demonstrate improved survival compared to chemotherapy and placebo, according to a recent clinical trial published in JAMA Oncology.
A type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results of a clinical trial published in JAMA Oncology.
By applying a sophisticated machine-learning approach to electronic health records of patients with pneumonia, investigators at Northwestern University have uncovered five distinct clinical states in pneumonia.
Northwestern Medicine investigators have created a novel blood test that identifies adults who may be at increased risk of developing severe respiratory illnesses, according to a recent study published in the American Journal of Respiratory and Critical Care Medicine.
Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.